Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Sanofi–GSK COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

    The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [8][9]

  3. List of COVID-19 vaccine authorizations - Wikipedia

    en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

    The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...

  4. GSK's RSV, Shingles vaccines show on-par immune ... - AOL

    www.aol.com/news/gsks-rsv-shingles-vaccines-show...

    The trial testing the immune response of co-administration of GSK's blockbuster vaccines, Shingrix and Arexvy, in adults over 50 years of age, met the main goal of the study. The co-administration ...

  5. Operation Warp Speed - Wikipedia

    en.wikipedia.org/wiki/Operation_Warp_Speed

    e. Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. [1][2] The first news report of Operation Warp Speed was on April 29, 2020, [3][4][5] and the program was ...

  6. US FDA expands GSK's RSV vaccine approval to adults ... - AOL

    www.aol.com/news/us-fda-expands-gsks-rsv...

    June 7, 2024 at 7:16 PM. By Sriparna Roy and Christy Santhosh. (Reuters) -The U.S. Food and Drug Administration approved the expanded use of GSK's respiratory syncytial virus (RSV) vaccine on ...

  7. GSK Sees Strong Demand For Vaccines and Asthma Drugs ... - AOL

    www.aol.com/finance/gsk-sees-strong-demand...

    Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency ...

  8. GSK plc - Wikipedia

    en.wikipedia.org/wiki/GSK_plc

    GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

  9. US CDC OKs use of new Pfizer, GSK vaccines for RSV in ... - AOL

    www.aol.com/news/us-cdc-recommends-pfizer-gsk...

    The vaccines are the first approved to prevent RSV, which causes around 14,000 deaths in adults aged 65 and older in the U.S. annually, according to government estimates. US CDC OKs use of new ...